G

Genedrive PLC
LSE:GDR

Watchlist Manager
Genedrive PLC
LSE:GDR
Watchlist
Price: 2.4 GBX -2.04% Market Closed
Market Cap: 13m GBX
Have any thoughts about
Genedrive PLC?
Write Note

Genedrive PLC
Cash Taxes Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genedrive PLC
Cash Taxes Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Taxes Paid CAGR 3Y CAGR 5Y CAGR 10Y
G
Genedrive PLC
LSE:GDR
Cash Taxes Paid
-ÂŁ956k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-58%
Oxford Nanopore Technologies PLC
LSE:ONT
Cash Taxes Paid
ÂŁ417k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Diaceutics PLC
LSE:DXRX
Cash Taxes Paid
-ÂŁ690k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ergomed PLC
LSE:ERGO
Cash Taxes Paid
ÂŁ3.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C4X Discovery Holdings PLC
LSE:C4XD
Cash Taxes Paid
-ÂŁ2.4m
CAGR 3-Years
4%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Cash Taxes Paid
-ÂŁ1.5m
CAGR 3-Years
-87%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Genedrive PLC
Glance View

Market Cap
13m GBX
Industry
Life Sciences Tools & Services

Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. The Company’s Genedrive device is a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company’s commercial products include Genedrive MT-RNR1, Genedrive BioPlex, Genedrive HCV ID Kit and Genedrive 96 SARS-CoV-2 Ki. Genedrive MT-RNR1 is a commercial test for antibiotic induced hearing loss. Genedrive BioPlex is developed for the determination of military biothreats from pathogens. Genedrive HCV ID Kit is effective in the diagnosis of Hepatitis C Virus (HCV) infection in resource limited settings. Genedrive 96 SARS-CoV-2 Ki is a plate format of a COVID-19 molecular test for high throughput use, which detects all known variants of COVID-19.

GDR Intrinsic Value
0.41 GBX
Overvaluation 83%
Intrinsic Value
Price
G

See Also

What is Genedrive PLC's Cash Taxes Paid?
Cash Taxes Paid
-956k GBP

Based on the financial report for Dec 31, 2023, Genedrive PLC's Cash Taxes Paid amounts to -956k GBP.

What is Genedrive PLC's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 10Y
-58%

Over the last year, the Cash Taxes Paid growth was 18%.

Back to Top